Inventor · disambiguated record
Mark Shenderovich
Also filed as: SHENDEROVICH MARK · SHENDEROVICH MARK D
4 granted patents·9 pending applications·35 citations·filing 2001–2015
70Inventor score
Files withALZHEIMER S INST OF AMERICA2MYRIAD PHARMACEUTICALS INC2BAJJI ASHOK C1CENGENT THERAPEUTICS1HOLCOMB RYAN1
Top patents by PatentIndex Score
13 records- 0191US7595401B2Therapeutic compounds and their use in cancerMYRIAD PHARMACEUTICALS INC·Filed 2007·Granted Sep 29, 2009·21 cites·34 claims
- 0274US6436933B1Inhibitors of anthrax lethal factor activitySTRUCTURAL BIOINFORMATICS INC·Filed 2001·Granted Aug 20, 2002·14 cites·3 claims
- 0362US8476285B2Purine-core inhibitors of HSP90 and their use in treating cancerBAJJI ASHOK C·Filed 2009·Granted Jul 2, 2013·0 cites·19 claims
- 0449US2015352108A1Amino-pyrimidine compounds as inhibitors of tbk1 and/or ikk epsilonALZHEIMER S INST OF AMERICA·Filed 2014·Application pending·0 cites
- 0548US2007197577A1Inhibitors of anthrax lethal factorCENGENT THERAPEUTICS·Filed 2004·Application pending·0 cites
- 0644US2012238540A1Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1HOLCOMB RYAN C·Filed 2012·Application pending·0 cites
- 0739US2014349989A1Compounds and therapeutic uses thereofALZHEIMER S INST OF AMERICA·Filed 2013·Application pending·0 cites
- 0837US2008070867A12-Imidazolone and 2-Imidazolidinone Heterocyclic Inhibitors of Tyrosine PhosphatasesMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0936US2006135773A1Trisubstituted nitrogen modulators of tyrosine phosphatasesSEMPLE JOSEPH E·Filed 2005·Application pending·0 cites
- 1036US2014288044A1Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitorsHOLCOMB RYAN·Filed 2012·Application pending·0 cites
- 1134US2012122840A1Compounds and therapeutic uses thereofKUMAR DANGE VIJAY·Filed 2011·Application pending·0 cites
- 1232US10849901B2Arf6 inhibitors and methods of synthesis and use thereofNAVIGEN INC·Filed 2015·Granted Dec 1, 2020·0 cites·12 claims
- 1332US2010292255A1Therapeutic Compounds and Their Use in Treating Diseases and DisordersMYRIAD PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →